217 related articles for article (PubMed ID: 21463793)
21. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
[TBL] [Abstract][Full Text] [Related]
22. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
23. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
[TBL] [Abstract][Full Text] [Related]
24. [Stent insertion as palliation of cancer in the esophagus and cardia].
Tangen M; Andresen SJ; Moum B; Hauge T
Tidsskr Nor Laegeforen; 2006 Jun; 126(12):1607-9. PubMed ID: 16770371
[TBL] [Abstract][Full Text] [Related]
25. Preliminary Results of Temporary Placement of Retrievable Expandable Metallic Stents during Preoperative Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer.
Park JH; Song HY; Shin JH; Kim JH; Kim YH; Kim SB; Kim JH
J Vasc Interv Radiol; 2015 Jun; 26(6):883-8. PubMed ID: 25724088
[TBL] [Abstract][Full Text] [Related]
26. Malignant dysphagia: palliation with esophageal stents--long-term results with 100 patients.
Coyle WJ; Lawson JM
Gastrointest Endosc; 1999 Jul; 50(1):134-5. PubMed ID: 10428620
[No Abstract] [Full Text] [Related]
27. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
Hölscher AH; Metzger R; Schneider PM
Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
[TBL] [Abstract][Full Text] [Related]
28. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
[TBL] [Abstract][Full Text] [Related]
29. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
[TBL] [Abstract][Full Text] [Related]
30. Self-expanding plastic stent removed after radiochemotherapy for advanced esophageal cancer.
Laquière A; Grandval P; Heresbach D; Prat F; Arpurt JP; Bichard P; D'Halluin PN; Berthillier J; Boustière C; Laugier R
Dis Esophagus; 2014; 27(2):176-81. PubMed ID: 23651038
[TBL] [Abstract][Full Text] [Related]
31. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma.
Homs MY; Steyerberg EW; Kuipers EJ; van der Gaast A; Haringsma J; van Blankenstein M; Siersema PD
Endoscopy; 2004 Oct; 36(10):880-6. PubMed ID: 15452784
[TBL] [Abstract][Full Text] [Related]
32. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
Lin FC; Durkin AE; Ferguson MK
Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
[TBL] [Abstract][Full Text] [Related]
33. Palliative treatment of esophageal tumors.
Lapenta R; Assisi D; Grassi A; Lauria V; Stigliano V; Casale V
J Exp Clin Cancer Res; 2002 Dec; 21(4):503-7. PubMed ID: 12636096
[TBL] [Abstract][Full Text] [Related]
34. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
35. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
Kim MP; Correa AM; Lee J; Rice DC; Roth JA; Mehran RJ; Walsh GL; Ajani JA; Maru DM; Chang JY; Marom EM; Macapinlac HA; Lee JH; Vaporciyan AA; Rice T; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2010 Sep; 90(3):884-90; discussion 890-1. PubMed ID: 20732513
[TBL] [Abstract][Full Text] [Related]
36. Improving results of esophageal stenting: a study on 160 consecutive unselected patients.
Segalin A; Bonavina L; Carazzone A; Ceriani C; Peracchia A
Endoscopy; 1997 Oct; 29(8):701-9. PubMed ID: 9427487
[TBL] [Abstract][Full Text] [Related]
37. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
38. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
39. Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long-Term Gastroesophageal Reflux and Quality of Life-Related Symptoms.
Philips P; North DA; Scoggins C; Schlegel M; Martin RC
J Am Coll Surg; 2015 Jul; 221(1):165-73. PubMed ID: 26095567
[TBL] [Abstract][Full Text] [Related]
40. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
